Entry |
|
Name |
Leridistim (USAN/INN) |
Formula |
C1550H2463N425O462S12
|
Exact mass |
34806.8949
|
Mol weight |
34828.4915
|
Sequence |
ANCSNMIDEI ITHLKQPPLP LLDFNNLNGE DQDILMDNNL RRPNLEAFNR AVKSLQNASA IESILKNLLP CLPLATAAPT RHPIHIKDGD WNEFRRKLTF YLKTLENAQA QQYVEGGGGS PGEPSGPIST INPSPPSKES HKSPNMATPL GPASSLPQSF LLKSLEQVRK IQGDGAALQE KLCATYKLCH PEELVLLGHS LGIPWAPLSS CPSQALQLAG CLSQLHSGLF LYQGLLQALE GISPELGPTL DTLQLDVADF ATTIWQQMEE LGMAPALQPT QGAMPAFASA FQRRAGGVLV ASHLQSFLEV SYRVLRHLAQ P |
Type |
Peptide |
Class |
Immunological agent
DG01753 Colony stimulating factor
|
Efficacy |
Antineutropenic, Antithrombocytopenia |
Comment |
Treatment of chemotherapy-induced neutropenia and thrombocytopenia (multifunctional agonist that activates both interleukin-3 and G-CSF receptors)
|
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
|
Brite |
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
D04695 Leridistim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL3RA (CD123)
D04695 Leridistim (USAN/INN)
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D04695 Leridistim (USAN/INN)
|
Other DBs |
|
LinkDB |
|